Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
BMJ Open|June 14, 2020
Prevalence of osteoporosis among North Korean women refugees living in South Korea: a comparative cross-sectional studyKyeong Jin Kim, Jee Hyun An, Kyoung Jin Kim, et al.
BMC Geriatrics|February 2, 2020
Development of a senior-specific, citizen-oriented healthcare service system in South Korea based on the Canadian 48/6 model of careYoon-Sook Kim, Jongmin Lee, Yeonsil Moon, et al.
Cardiovascular Diabetology|March 13, 2019
Dipeptidyl peptidase-4 inhibitor compared with sulfonylurea in combination with metformin: cardiovascular and renal outcomes in a propensity-matched cohort studyKyoung Jin Kim, Jimi Choi, Juneyoung Lee, et al.
Journal of Internal Medicine|March 11, 2026
Persistent and emerging cancer risks after migration: Evidence from North and South Korean cohortsJunshik Hong, Kyeong Jin Kim, Jimi Choi, et al.
Endocrinology and Metabolism (Seoul, Korea)|January 13, 2025
Unveiling Risk Factors for Treatment Failure in Patients with Graves' Disease: A Nationwide Cohort Study in KoreaJung A Kim, Kyeong Jin Kim, Jimi Choi, et al.
Scientific Reports|April 15, 2025
Crystal growth and characterization of 1-inch GTAGG: Ce single crystal for sub-micron resolution synchrotron radiation X-ray imagingKazuya Omuro, Masao Yoshino, Liudmila Gushchina, et al.
Journal of Lipid and Atherosclerosis|October 8, 2021
Statin Therapy and the Risk of Osteoporotic Fractures in Patients with Metabolic Syndrome: a Nested Case-Control StudyKyoung Jin Kim, Jimi Choi, Ji Yoon Kim, et al.
European Journal of Endocrinology|November 14, 2019
Actual causes of death in thyroid cancer patients in Korea: A Nationwide Case Control Cohort StudyKyeong Jin Kim, Sujung Jang, Kyoung Jin Kim, et al.
BMC Immunology|May 10, 2024
GNUV201, a novel human/mouse cross-reactive and low pH-selective anti-PD-1 monoclonal antibody for cancer immunotherapyHae-Mi Kim, Kyoung-Jin Kim, Kwanghyun Lee, et al.
Diabetes, Obesity & Metabolism|May 15, 2020
Efficacy and safety of lobeglitazone versus sitagliptin as an add-on to metformin in patients with type 2 diabetes with two or more components of metabolic syndrome over 24 weeksSin Gon Kim, Kyoung Jin Kim, Kun Ho Yoon, et al.
Pageof 12